A phase II study of second-line S-1/CPT-11+bev for advanced colon cancer (NCCSG04): Subset analysis by K-ras, EGFR, UGT1A1, and previous bevacizumab.
Yasumasa Takii
No relevant relationships to disclose
Kouichi Furukawa
No relevant relationships to disclose
Satoshi Maruyama
No relevant relationships to disclose
Toshiyuki Yamazaki
No relevant relationships to disclose
Atsushi Nishimura
No relevant relationships to disclose
Mikako Kawahara
No relevant relationships to disclose
Takemi Tomiyama
No relevant relationships to disclose
Kohei Akazawa
No relevant relationships to disclose
Katsuyoshi Hatakeyama
No relevant relationships to disclose